|Place of Origin:||China|
|Model Number:||15mg/5ml, 100ml|
|Minimum Order Quantity:||50, 000 bottles|
|Packaging Details:||one bottle/box|
|Payment Terms:||L/C, T/T|
|Supply Ability:||50, 000 bottles per day|
|Product:||Ambroxol Syrup||Specification:||15mg/5ml, 100ml|
|Standard:||BP, USP||Packing:||One Bottle/box|
Ambroxol Syrup 15mg/5ml, 100ml Oral Medications
Product : Ambroxol Syrup
Specification : 15mg/5ml, 100ml
Standard : BP, USP
Packing : one bottle/box
Ambroxol is a clinically proven systemically active mucolytic agent. When administered orally onset of action occurs after about 30 minutes. The breakdown of acid mucopolysaccharide fibers makes the sputum thinner and less viscous and therefore more easily removed by coughing. Although sputum volume eventually decreases, its viscosity remains low for as long as treatment is maintained.
Indications and Usage :
All forms of tracheobronchitis, emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, bronchiectasis, bronchitis with bronchospasm asthma. During acute exacerbations of bronchitis it should be given with the appropriate antibiotic.
Mechanism of action :
Ambroxol is a mucolytic agent. Excessive Nitric oxide (NO) is associated with inflammatory and some other disturbances of airways function. NO enhances the activation of soluble guanylate cyclase and cGMP accumulation. Ambroxol has been shown to inhibit the NO-dependent activation of soluble guanylate cyclase. It is also possible that the inhibition of NO-dependent activation of soluble guanylate cyclase can suppress the excessive mucus secretion, therefore it lowers the phlegm viscosity and improves the mucociliary transport of bronchial secretions.